Paladin Partners’s MetLife MET Stock Holding History

Paladin Partners’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-300	Closed	-$21.2K	–	217
2026 Q1	$21.2K	Sell	300 -50	-14%	-$3.74K	0.02%	104
2025 Q4	$27.6K	Buy	+350	New	+$27.7K	0.02%	94

Other funds holding MET

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Paladin Partners's MET Position: Q2 2026 in Review

Paladin Partners sold out of MetLife (MET) in Q2 2026, closing a stake of 300 shares — an estimated $21.2K sold.

Paladin Partners first reported a position in MET in Q4 2025 and held it in 2 quarters. The position peaked at $27.6K in Q4 2025. 1,438 funds tracked by Wall St. Rank hold MET as of Q2 2026.

Paladin Partners reported no remaining MetLife position as of Q2 2026 after selling out during the quarter.
Paladin Partners sold 300 MetLife shares in Q2 2026, an estimated $21.2K.
Paladin Partners first reported a position in MetLife in Q4 2025 and held it in 2 quarters.
Paladin Partners's MetLife position peaked at $27.6K in Q4 2025.
1,438 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Paladin Partners's 13F filing for Q2 2026, filed 7 Aug 2026.